Patents in nanotechnology applied to health: technological trends involving skin disorders
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoparticles: synthesis and applications · 3D Printing in Biomedical Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (58)
Show source-provided references
1. Griffiths TW, Watson REB, Langton AK (2023) Skin ageing and topical rejuvenation strategies. Br J Dermatol 189:I17–I2310.1093/bjd/ljad282 ↗
2. Khavkin J, Ellis DAF (2011) Aging skin: histology, physiology, and pathology. Facial Plast Surg Clin North Am 19:229–23410.1016/j.fsc.2011.04.003 ↗
3. Nature Outlook (2018) Skin Nature 563:S8310.1038/d41586-018-07428-4 ↗
4. Pandey A, Jatana GK, Sonthalia S (2023) Cosmeceuticals. Personal Care Products and Human Health 79–95. https://doi.org/10.1016/B978-0-323-99684-6.00007-010.1016/B978-0-323-99684-6.00007-0 ↗
5. Martin KI, Glaser DA (2011) Cosmeceuticals: The New Medicine of Beauty. Science of Medicine
6. Wani TU, Mohi-ud-Din R, Majeed A et al (2020) Skin permeation of nanoparticles: mechanisms involved and critical factors governing topical drug delivery. Curr Pharm Des 26:4601–4614. https://doi.org/10.2174/138161282666620070120401010.2174/1381612826666200701204010 ↗
7. Ghasemiyeh P, Mohammadi-Samani S (2020) Potential of nanoparticles as permeation enhancers and targeted delivery options for skin: advantages and disadvantages. Drug Des Devel Ther 14:3271–3289. https://doi.org/10.2147/DDDT.S26464810.2147/DDDT.S264648 ↗
8. Chang J, Yu B, Saltzman WM, Girardi M (2023) Nanoparticles as a therapeutic delivery system for skin cancer prevention and treatment. JID Innov 3:10019710.1016/j.xjidi.2023.100197 ↗
9. Raszewska-Famielec M, Flieger J (2022) Nanoparticles for topical application in the treatment of skin dysfunctions—an overview of dermo-cosmetic and dermatological products. Int J Mol Sci 23:1598010.3390/ijms232415980 ↗
10. Lopalco A, Denora N (2018) Nanoformulations for drug delivery: safety, toxicity, and efficacy. In: Orazio Nicolotti10.1007/978-1-4939-7899-1_17 ↗
11. (ed) Computational Toxicology: Methods and Protocols, Methods in Molecular Biology, vol 1800, pp 347-365
12. Chandra J, Hasan N, Nasir N et al (2023) Nanotechnology-empowered strategies in treatment of skin cancer. Environ Res 235:11664910.1016/j.envres.2023.116649 ↗
13. Bhattacharya S, Sharma S (2023) Dacarbazine-encapsulated solid lipid nanoparticles for skin cancer: physical characterization, stability, in-vivo activity, histopathology, and immunohistochemistry. Front Oncol 13:1102269. https://doi.org/10.3389/fonc.2023.110226910.3389/fonc.2023.1102269 ↗
14. Chen Y, Feng X (2022) Gold nanoparticles for skin drug delivery. Int J Pharm 625:12212210.1016/j.ijpharm.2022.122122 ↗
15. Vasam M, Korutla S, Bohara RA (2023) Acne vulgaris: a review of the pathophysiology, treatment, and recent nanotechnology based advances. Biochem Biophys Rep 36:101578
16. Chakraborty N, Narayanan V, Gautam HK (2022) Nano-therapeutics to treat acne vulgaris. Indian J Microbiol 62:167–17410.1007/s12088-022-01001-4 ↗
17. Farage MA, Miller KW, Elsner P, Maibach HI (2007) Structural characteristics of the aging skin: a review. Cutan Ocul Toxicol 26:343–357. https://doi.org/10.1080/1556952070162295110.1080/15569520701622951 ↗
18. Dréno B, Alexis A, Chuberre B, Marinovich M (2019) Safety of titanium dioxide nanoparticles in cosmetics. J Eur Acad Dermatol Venereol 33:34–4610.1111/jdv.15943 ↗
19. Gupta S, Bansal R, Gupta S et al (2013) Nanocarriers and nanoparticles for skin care and dermatological treatments. Indian Dermatol Online J 4:267. https://doi.org/10.4103/2229-5178.12063510.4103/2229-5178.120635 ↗
20. WIPO (2009) World Intellectual Property Indicators. https://www.wipo.int/publications/en/details.jsp?id=188. Accessed 15 Aug 2024
21. WIPO (2012) World Intellectual Property Indicators. https://www.wipo.int/publications/en/details.jsp?id=273. Accessed 15 Aug 2024
22. WIPO (2017) World Intellectual Property Indicators. https://www.wipo.int/publications/en/details.jsp?id=4234. Accessed 15 Aug 2024
23. Socal Mp, Sharfstein JM, Greene JA (2021) The Pandemic and the Supply Chain: Gaps in Pharmaceutical Production and Distribution. Am J Public Health 111(4)10.2105/AJPH.2020.306138 ↗
24. UT institutions recognized for innovation – ranked no. 3 in annual patent rankings for U.S. universities for second straight year | The University of Texas System. https://www.utsystem.edu/news/2024/06/05/ut-institutions-recognized-innovation-ranked-no-3-annual-patent-rankings-us-universities-second-straight-year. Accessed 19 Jun 2024
25. Ian C (2014) Low density lipoprotein nanocarriers for targeted delivery of omega-3 polyunsaturated fatty acids to cancer
26. Rotter JA, Jilin, (2017) Methods and compositions for TUSC2 immunotherapy. Texas, USA
27. Home - Cartesian. https://www.cartesiantherapeutics.com/. Accessed 14 Apr 2024
28. Peter I, Grayson BL, Charles Z (2010) Dose selection of adjuvanted synthetic nanocarriers
29. dos Santos Fonseca LM, Machado BAS, Oliveira FO et al (2024) An overview on recent patents and technologies on nanoparticles for nucleic acid delivery. Expert Opin Ther Pat 34:171–186. https://doi.org/10.1080/13543776.2024.233809710.1080/13543776.2024.2338097 ↗
30. Kim J, Eygeris Y, Gupta M, Sahay G (2021) Self-assembled mRNA vaccines. Adv Drug Deliv Rev 170:83–11210.1016/j.addr.2020.12.014 ↗
31. HaldAlbertsen C, Kulkarni JA, Witzigmann D et al (2022) The role of lipid components in lipid nanoparticles for vaccines and gene therapy. Adv Drug Deliv Rev 188:11441610.1016/j.addr.2022.114416 ↗
32. Almanghadim HG, Nourollahzadeh Z, Khademi NS et al (2021) Application of nanoparticles in cancer therapy with an emphasis on cell cycle. Cell Biol Int 45:1989–1998. https://doi.org/10.1002/cbin.1165810.1002/cbin.11658 ↗
33. Joshua F, Suzanne H, Ailin B et al (2016) Polynucleotides coding interleukin-12 (IL12), and applications thereof
34. Alireza K, Wujin S (2020) Biodegradable microneedle patch for transdermal gene delivery
35. Magnus B, Mustafa D, Gerald J et al (2012) Pharmaceutical compositions
36. Gonzalez RD, Astals AS, Courtois A, Thollas B (2013) Exopolisacárido para el tratamiento y/o cuidado de la piel, mucosas, cabello y/o uñas
37. De Beer J (2014) Hybridosomes, compositions comprising the same, processes for their production and uses thereof
38. Kim S, Yoo JDD, Jeon IS et al (2020) Ferritin nanocage fused with PD-L1-binding peptide 1 and use thereof as anticancer immunotherapy agent
39. Karl L (2001) External preparation for skin having acnegenic tendency
40. Warren JS (2013) Prostaglandin F2 alpha and analogs thereof for treating in the formation of atrophic skin scars
41. Maciel MAM (2019) Nanoformulação desenvolvida à base de óleo de copaíba para uso tópico em processo de cicatrização associado com laser
42. Desai P, Patlolla RR, Singh M (2010) Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery. Mol Membr Biol 27:247–25910.3109/09687688.2010.522203 ↗
43. Najahi-Missaoui W, Arnold RD, Cummings BS (2021) Safe nanoparticles: are we there yet? Int J Mol Sci 22:1–22. https://doi.org/10.3390/ijms2201038510.3390/ijms22010385 ↗
44. Lim C, Lee S, Shin Y et al (2023) Development and application of novel peptide-formulated nanoparticles for treatment of atopic dermatitis. J Mater Chem B 11:10131–10146. https://doi.org/10.1039/D3TB01202F10.1039/D3TB01202F ↗
45. Lapteva M, Santer V, Mondon K et al (2014) Targeted cutaneous delivery of ciclosporin A using micellar nanocarriers and the possible role of inter-cluster regions as molecular transport pathways. J Control Release 196:9–18. https://doi.org/10.1016/J.JCONREL.2014.09.02110.1016/J.JCONREL.2014.09.021 ↗
46. Al-Momani H, Massadeh MI, Almasri M et al (2024) Anti-bacterial activity of green synthesised silver and zinc oxide nanoparticles against Propionibacterium acnes. Pharmaceuticals 17:255. https://doi.org/10.3390/ph1702025510.3390/ph17020255 ↗
47. Folle C, Marqués AM, Díaz-Garrido N et al (2021) Thymol-loaded PLGA nanoparticles: an efficient approach for acne treatment. J Nanobiotechnology 19:1–21. https://doi.org/10.1186/s12951-021-01092-z10.1186/s12951-021-01092-z ↗
48. Han J, Wu T, Jin J et al (2022) Exosome-like nanovesicles derived from Phellinus linteus inhibit Mical2 expression through cross-kingdom regulation and inhibit ultraviolet-induced skin aging. J Nanobiotechnology 20:455. https://doi.org/10.1186/s12951-022-01657-610.1186/s12951-022-01657-6 ↗
49. Elsheikh MA, Gaafar PME, Khattab MA et al (2023) Dual-effects of caffeinated hyalurosomes as a nano-cosmeceutical gel counteracting UV-induced skin ageing. Int J Pharm X 5:100170. https://doi.org/10.1016/J.IJPX.2023.10017010.1016/J.IJPX.2023.100170 ↗
50. Zhou Y, Chen R, He T et al (2016) Biomedical potential of ultrafine Ag/AgCl nanoparticles coated on graphene with special reference to antimicrobial performances and burn wound healing. ACS Appl Mater Interfaces 8:15067–15075. https://doi.org/10.1021/acsami.6b0302110.1021/acsami.6b03021 ↗
51. Franková J, Pivodová V, Vágnerová H et al (2016) Effects of silver nanoparticles on primary cell cultures of fibroblasts and keratinocytes in a wound-healing model. J Appl Biomater Funct Mater 14:e137–e142. https://doi.org/10.5301/jabfm.500026810.5301/jabfm.5000268 ↗
52. Rozman NAS, Tong WY, Leong CR et al (2020) Homalomena pineodora essential oil nanoparticle inhibits diabetic wound pathogens. Sci Rep 10:3307. https://doi.org/10.1038/s41598-020-60364-010.1038/s41598-020-60364-0 ↗
53. Wang H, Wang Z (2023) The difference in the curative effects of 5-aminolevulinic acid nano-gold photodynamic therapy and 1550 nm erbium glass fractional laser therapy in severe rosacea. Applied Nanoscience (Switzerland) 13:3493–3501. https://doi.org/10.1007/s13204-022-02642-z10.1007/s13204-022-02642-z ↗
54. Cao M, Yan H, Han X et al (2019) Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth. J Immunother Cancer 7:1–8. https://doi.org/10.1186/S40425-019-0817-410.1186/S40425-019-0817-4 ↗
55. Espacenet – patent classification. https://worldwide.espacenet.com/patent/cpc-browser#!/CPC=A61K9/51. Accessed 18 Apr 2024
56. Skin Treatment - Worldwide | Statista Market Forecast. https://www.statista.com/outlook/cmo/otc-pharmaceuticals/skin-treatment/worldwide. Accessed 11 Apr 2024
57. Cosmetics - Worldwide | Statista Market Forecast. https://www.statista.com/outlook/cmo/beauty-personal-care/cosmetics/worldwide. Accessed 11 Apr 2024
58. Elliott G (2007) Basics of US patents and the patent system. American Association of Pharmaceutical Scientists 9(3)10.1208/aapsj0903035 ↗